The effect of lycopene on serum level of cardiac biomarkers
Phase 3
- Conditions
- Patients undergoing elective coronary intervention (PCI) treatment.
- Registration Number
- IRCT20191018045149N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patient undergoing elective PCI surgery over 40 years old.
Consumption of 80 to 100 mg aspirin daily for at least 5 days before PCI
Completion of informed consent
No Consumption of other antioxidants including vitamins C and E, coenzyme Q10, selenium, anthocyanin supplements and lycopene supplements 1 week before study
No use of fish oil and omega-3 by 1 week before study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of CK-MB, Troponin I and hs-CRP were measured in patients. Timepoint: Blood samples from both groups 12 hours before the intervention, 8 and 12 hours one and six months after the intervention. Method of measurement: 5 ml blood was taken from the patient to measure serum CK-MB, Troponin I and hs-CRP levels.
- Secondary Outcome Measures
Name Time Method